The US Food and Drug Administration has expanded the use of Novartis' drug to treat adults with ​a chronic skin condition that causes recurring itchy welts, ‌the Swiss drugmaker said on Wednesday.

Log in or sign up to comment.

No comments yet.

← Back to stories